Free Trial

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$4.60 -0.24 (-4.96%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$4.88 +0.28 (+5.98%)
As of 05/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU vs. LNSR, SRTS, DRIO, ECOR, and DXR

Should you buy SeaStar Medical stock or one of its competitors? MarketBeat compares SeaStar Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SeaStar Medical include LENSAR (LNSR), Sensus Healthcare (SRTS), DarioHealth (DRIO), electroCore (ECOR), and Daxor (DXR). These companies are all part of the "medical equipment" industry.

How does SeaStar Medical compare to LENSAR?

SeaStar Medical (NASDAQ:ICU) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 66.0% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

SeaStar Medical has a beta of -1.04, suggesting that its share price is 204% less volatile than the broader market. Comparatively, LENSAR has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

LENSAR has a net margin of 50.94% compared to SeaStar Medical's net margin of -984.60%. LENSAR's return on equity of -183.19% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-984.60% -188.47% -106.42%
LENSAR 50.94%-183.19%42.26%

In the previous week, SeaStar Medical and SeaStar Medical both had 7 articles in the media. SeaStar Medical's average media sentiment score of 0.96 beat LENSAR's score of 0.84 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LENSAR
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SeaStar Medical currently has a consensus price target of $6.00, suggesting a potential upside of 30.43%. LENSAR has a consensus price target of $10.00, suggesting a potential upside of 73.31%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SeaStar Medical has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M14.96-$12.15M-$8.30N/A
LENSAR$58.44M1.19-$34.28M-$0.58N/A

Summary

LENSAR beats SeaStar Medical on 11 of the 15 factors compared between the two stocks.

How does SeaStar Medical compare to Sensus Healthcare?

SeaStar Medical (NASDAQ:ICU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

SeaStar Medical currently has a consensus price target of $6.00, indicating a potential upside of 30.43%. Sensus Healthcare has a consensus price target of $6.88, indicating a potential upside of 99.28%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Sensus Healthcare
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

SeaStar Medical has a beta of -1.04, suggesting that its share price is 204% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Sensus Healthcare has a net margin of -34.50% compared to SeaStar Medical's net margin of -984.60%. Sensus Healthcare's return on equity of -15.41% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-984.60% -188.47% -106.42%
Sensus Healthcare -34.50%-15.41%-13.70%

Sensus Healthcare has higher revenue and earnings than SeaStar Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M14.96-$12.15M-$8.30N/A
Sensus Healthcare$27.48M2.07-$7.72M-$0.47N/A

In the previous week, Sensus Healthcare had 6 more articles in the media than SeaStar Medical. MarketBeat recorded 13 mentions for Sensus Healthcare and 7 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.96 beat Sensus Healthcare's score of 0.10 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sensus Healthcare
1 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Sensus Healthcare beats SeaStar Medical on 13 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to DarioHealth?

SeaStar Medical (NASDAQ:ICU) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

SeaStar Medical has higher earnings, but lower revenue than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M14.96-$12.15M-$8.30N/A
DarioHealth$22.36M2.64-$41.71M-$10.43N/A

SeaStar Medical has a beta of -1.04, suggesting that its share price is 204% less volatile than the broader market. Comparatively, DarioHealth has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 3.5% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

DarioHealth has a net margin of -186.57% compared to SeaStar Medical's net margin of -984.60%. DarioHealth's return on equity of -59.48% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-984.60% -188.47% -106.42%
DarioHealth -186.57%-59.48%-36.94%

SeaStar Medical presently has a consensus price target of $6.00, indicating a potential upside of 30.43%. DarioHealth has a consensus price target of $35.00, indicating a potential upside of 332.10%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts clearly believe DarioHealth is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
DarioHealth
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

In the previous week, SeaStar Medical had 1 more articles in the media than DarioHealth. MarketBeat recorded 7 mentions for SeaStar Medical and 6 mentions for DarioHealth. SeaStar Medical's average media sentiment score of 0.96 beat DarioHealth's score of 0.93 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DarioHealth
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

DarioHealth beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to electroCore?

SeaStar Medical (NASDAQ:ICU) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

SeaStar Medical has a beta of -1.04, suggesting that its stock price is 204% less volatile than the broader market. Comparatively, electroCore has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

SeaStar Medical has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M14.96-$12.15M-$8.30N/A
electroCore$32.03M1.64-$13.97M-$1.77N/A

electroCore has a net margin of -44.08% compared to SeaStar Medical's net margin of -984.60%. SeaStar Medical's return on equity of -188.47% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-984.60% -188.47% -106.42%
electroCore -44.08%-1,956.38%-83.30%

SeaStar Medical presently has a consensus price target of $6.00, indicating a potential upside of 30.43%. electroCore has a consensus price target of $18.00, indicating a potential upside of 184.81%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, electroCore had 13 more articles in the media than SeaStar Medical. MarketBeat recorded 20 mentions for electroCore and 7 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.96 beat electroCore's score of 0.41 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
electroCore
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 13.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

electroCore beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Daxor?

SeaStar Medical (NASDAQ:ICU) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

Daxor has lower revenue, but higher earnings than SeaStar Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M14.96-$12.15M-$8.30N/A
DaxorN/AN/AN/AN/AN/A

Daxor has a net margin of 0.00% compared to SeaStar Medical's net margin of -984.60%. Daxor's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-984.60% -188.47% -106.42%
Daxor N/A N/A N/A

SeaStar Medical has a beta of -1.04, suggesting that its share price is 204% less volatile than the broader market. Comparatively, Daxor has a beta of 0.29, suggesting that its share price is 71% less volatile than the broader market.

In the previous week, SeaStar Medical had 6 more articles in the media than Daxor. MarketBeat recorded 7 mentions for SeaStar Medical and 1 mentions for Daxor. Daxor's average media sentiment score of 1.89 beat SeaStar Medical's score of 0.96 indicating that Daxor is being referred to more favorably in the news media.

Company Overall Sentiment
SeaStar Medical Positive
Daxor Very Positive

SeaStar Medical currently has a consensus target price of $6.00, indicating a potential upside of 30.43%. Given SeaStar Medical's higher probable upside, research analysts plainly believe SeaStar Medical is more favorable than Daxor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Daxor
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 59.5% of Daxor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Daxor beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$19.34M$8.31B$6.30B$12.20B
Dividend YieldN/A2.92%2.79%5.30%
P/E Ratio-0.5522.9521.0025.58
Price / Sales14.9615.56554.5578.84
Price / CashN/A83.9542.9455.34
Price / Book1.675.629.756.66
Net Income-$12.15M$183.43M$3.55B$333.63M
7 Day Performance-5.35%0.28%-0.53%-0.11%
1 Month Performance22.67%5.23%1.20%3.94%
1 Year Performance-62.60%4.94%41.22%36.07%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
1.6933 of 5 stars
$4.60
-5.0%
$6.00
+30.4%
-63.8%$19.34M$1.23MN/A2
LNSR
LENSAR
2.131 of 5 stars
$5.48
-1.4%
$10.00
+82.5%
-58.8%$66.29M$58.44MN/A110
SRTS
Sensus Healthcare
3.7825 of 5 stars
$3.93
-0.8%
$6.88
+74.9%
-24.8%$64.70M$27.48MN/A40
DRIO
DarioHealth
2.8543 of 5 stars
$7.99
+7.2%
$35.00
+338.0%
-43.9%$58.33M$22.36MN/A200
ECOR
electroCore
2.5676 of 5 stars
$6.99
+4.6%
$18.00
+157.5%
+33.9%$56.51M$32.03MN/A50

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners